大阪大学・呼吸器内科（８研）
大阪大学大学院医学系研究科　呼吸器・免疫アレルギー内科学
Dept. of Respiratory Medicine, Allergy and Rheumatic Disease, Graduate School of Medicine, Osaka University.
HOME
研究業績
HOME ＞ 研究業績
2012年
  1. Takeda Y, Nakanishi K, Tachibana I, Kumanogoh A.　Adiponectin: A Novel Link Between Adipocytes and COPD.　Vitam Horm. 2012;90:419-35
  2. Ihara S, Kida H, Arase H, Tripathi LP, Chen YA, Kimura T, Yoshida M, Kashiwa Y, Hirata H, Fukamizu R, Inoue R, Hasegawa K, Goya S, Takahashi R, Minami T, Tsujino K, Suzuki M, Kohmo S, Inoue K, Nagatomo I, Takeda Y, Kijima T, Mizuguchi K, Tachibana I, Kumanogoh A. Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis.Cancer Res. 2012 Jun 15;72(12):2990-2999. 2012 Epub
  3. Tsujino K, Takeda Y, Arai T, Shintani Y, Inagaki R, Saiga H, Iwasaki T, Tetsumoto S, Jin Y, Ihara S, Minami T, Suzuki M, Nagatomo I, Inoue K, Kida H, Kijima T, Ito M, Kitaichi M, Inoue Y, Tachibana I, Takeda K, Okumura M, Hemler ME, Kumanogoh A.Tetraspanin CD151 Protects against Pulmonary Fibrosis by Maintaining Epithelial Integrity.Am J Respir Crit Care Med. 2012 May 16. Epub
  4. Minami T, Kijima T, Otani Y, Kohmo S, Takahashi R, Nagatomo I, Hirata H, Suzuki M, Inoue K, Takeda Y, Kida H, Tachibana I, Kumanogoh A. HER2 As Therapeutic Target for Overcoming ATP-Binding Cassette Transporter-Mediated Chemoresistance in Small Cell Lung Cancer.Mol Cancer Ther.11(4):830-41. Epub
  5. Kohmo S, Kijima T, Mori M, Minami T, Namba Y, Yano Y, Yoneda T, Takeda Y, Kitada S, Yamaguchi T, Tachibana I, Yokota S.CXCL12 as a biological marker for the diagnosis of tuberculous pleurisy.Tuberculosis (Edinb). 2012. [Epub ahead of print]
  6. Takahashi R, Hirata H, Tachibana I, Shimosegawa E, Inoue A, Nagatomo I, Takeda Y, Kida H, Goya S, Kijima T, Yoshida M, Kumagai T, Kumanogoh A, Okumura M, Hatazawa J, Kawase I., Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung.Clin Cancer Res.18(1):220-8. 2012
2011年
  1. Kijima T, Takeuchi K, Tetsumoto S, Shimada K, Takahashi R, Hirata H, Nagatomo I, Hoshino S, Takeda Y, Kida H, Goya S, Tachibana I, Kawase I.,Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer.Cancer Sci. Aug;102(8):1602-4.2011
  2. Honda H, Kida H, Yoshida M, Tomita T, Fujii M, Ihara S, Goya S, Tachibana I, Kawase I., TRecurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab.Mod Rheumatol. (6):660-4.2011
  3. Tetsumoto S, Osa A, Kijima T, Minami T, Hirata H, Takahashi R, Kuhara H, Nagatomo I, Takeda Y, Kida H, Goya S, Tachibana I, Kawase I. Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib.Int J Clin Oncol. 2011 May 19.[Epub ahead of print]
  4. Takeda Y, Li Q, Kazarov AR, Epardaud M, Elpek K, Turley SJ, Hemler ME. Diminished metastasis in tetraspanin CD151 knockout mice.Blood. May 2.[Epub ahead of print]
  5. Nakanishi K, Takeda Y, Tetsumoto S, Iwasaki T, Tsujino K, Kuhara H, Jin Y, Nagatomo I, Kida H, Goya S, Kijima T, Maeda N, Funahashi T, Shimomura I, Tachibana I, Kawase I.Involvement of Endothelial Apoptosis Underlying COPD-Like Phenotype in Adiponectin-Null Mice: Implications for Therapy.Am J Respir Crit Care Med.183(9):1164-75[Epub ahead of print]
  6. Kijima T, Shimizu T, Nonen S, Furukawa M, Otani Y, Minami T, Takahashi R, Hirata H, Nagatomo I, Takeda Y, Kida H, Goya S, Fujio Y, Azuma J, Tachibana I, Kawase I. Safe and Successful Treatment With Erlotinib After Gefitinib-Induced Hepatotoxicity: Difference in Metabolism As a Possible Mechanism. J Clin Oncol. 2011 Apr 18. [Epub ahead of print]
  7. Shiroyama T, Komuta K, Imamura F, Hirashima T, Kijima T, Tachibana I, Kawase I. Phase II study of S-1 monotherapy in platinum-refractory, advanced non-small cell lung cancer. Lung Cancer.[Epub ahead of print]
2010年
  1. Iwasaki T, Tachibana I, Yoshida S, Shimazu K, Takeda Y, Nagano H, Kawase I.,A 61-year-old man with a lung nodule and elevated serum IgG. .Chest.137(5):1232-5.2010
  2. Kohmo S, Kijima T, Otani Y, Mori M, Minami T, Takahashi R, Nagatomo I, Takeda Y, Kida H, Goya S, Yoshida M, Kumagai T, Tachibana I, Yokota S, Kawase I. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.Cancer Res.70(20):8025-35.
  3. Iwahori K, Serada S, Fujimoto M, Nomura S, Osaki T, Lee CM, Mizuguchi H, Takahashi T, Ripley B, Okumura M, Kawase I, Kishimoto T, Naka T. Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma. Int J Cancer 2010 Oct 14.
2009年
  1. Suzuki M, Tachibana I, Takeda Y, He P, Minami S, Iwasaki T, Kida H, Goya S, Kijima T, Yoshida M, Kumagai T, Osaki T, Kawase I. Tetraspanin CD9 negatively regulates lipopolysaccharide-induced macrophage activation and lung inflammation. J Immunol. 2009 May 15;182(10):6485-93.2009
  2. Freudenberg JA, Wang Q, Katsumata M, Drebin J, Nagatomo I, Greene MI.,The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies. . Exp Mol Pathol. 87(1):1-11.2009
  3. He R, Kim HY, Yoon J, Oyoshi MK, MacGinnitie A, Goya S, Freyschmidt EJ, Bryce P, McKenzie AN, Umetsu DT, Oettgen HC, Geha RS.Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.,J Allergy Clin Immunol. 124(4):761-70.2009
2008年
  1. Takeda Y, He P, Tachibana I, Zhou B, Miyado K, Kaneko H, Suzuki M, Minami S, Iwasaki T, Goya S, Kijima T, Kumagai T, Yoshida M, Osaki T, Komori T, Mekada E,Kawase I. Double deficiency of tetraspanins CD9 and CD81 Alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice.J Biol Chem. 2008 Sep 19;283(38):26089-97. Epub 2008 Jul 28.
  2. Iwahori K, Osaki T, Serada S, Fujimoto M, Suzuki H, Kishi Y, Yokoyama A, Hamada H, Fujii Y, Yamaguchi K, Hirashima T, Matsui K, Tachibana I, Nakamura Y, Kawase I, Naka T. Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: Evaluation in comparison with mesothelin. Lung Cancer. 2008 Apr 2. [Epub ahead of print]
  3. Takimoto T, Yoshida M, Hirata H, Suzuki M, Yanagita M, Kashiwa Y, Inoue K, Yano Y, Hoshino S, Takeda Y, Goya S, Kijima T, Kumagai T, Osaki T, Tachibana I, Kawase I. 4-Hydroxy-2-nonenal induces endothelial cell injury via PKCdelta and biphasic JNK activationEXCLI Journal 2008;7:71-78
2007年
  1. Kijima T, Suzuki M, Ueda K, Minami S, Takeda Y, Goya S, Matsuoka H, Kumagai T, Yoshida M, Osaki T, Tachibana I, Yokota S, Kawase I.Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report.Oncol Res. 2007;16(10):489-95.
  2. Yanagita M, Yoshida M, Hoshino S, Yano Y, Inoue K, Takimoto T, Hirata H, Kashiwa Y, Kumagai T, Osaki T, Kijima T, Tachibana I, Kawase I. Anti-fibrotic Effects of ONO-EF-345, a Specific Phosphodiesterase IV inhibitor, on Lung Fibroblasts. EXCLI Journal 2007;6:23 - 35
  3. Furukawa M, Nagatomo I, Kumagai T, Yamadori T, Takahashi R, Yoshimura M, Yoneda T, Takeda Y, Goya S, Matsuoka H, Kijima T, Yoshida M, Osaki T, Tachibana I, Greene MI, Kawase I. Gefitinib-sensitive EGFR lacking residues 746-750 exhibits hypophosphorylation at tyrosine residue 1045, hypoubiquitination, and impaired endocytosis. DNA Cell Biol. 2007 Mar;26(3):178-85.
  4. He P, Naka T, Serada S, Fujimoto M, Tanaka T, Hashimoto S, Shima Y, Yamadori T, Suzuki H, Hirashima T, Matsui K, Shiono H, Okumura M, Nishida T, Tachibana I, Norioka N, Norioka S, Kawase I. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci. 2007 Aug;98(8):1234-40. Epub 2007 May 15.
  5. Hoshino S, Tachibana I, Kijima T, Yoshida M, Kumagai T, Osaki T, Kamei K, Kawase I. A 60-year-old woman with cough, fever, and upper-lobe cavitary consolidation. Chest. 2007 Aug;132(2):708-10.
  6. Kitaoka H, Kawase I. A novel interpretation of closing volume based on single-breath nitrogen washout curve simulation. J Physiol Sci. 2007 Dec;57(6):367-76.
  7. Kitaoka H, Nieman GF, Fujino Y, Carney D, DiRocco J, Kawase I. A 4-dimensional model of the alveolar structure. J Physiol Sci. 2007 Jun;57(3):175-85.
  8. Kohmo S, Tachibana I, Osaki T, Goya S, Matsuoka H, Kijima T, Yoshida M, Kumagai T, Ikeda J, Aozasa K, Kawase I. Multiple organ mucosa-associated lymphoid tissue lymphoma presenting with lymphangitic pattern of spread in the lung.J Thorac Oncol. 2007 Nov;2(11):1057-9.
2006年
  1. Yano Y, Yoshida M, Hoshino S, Inoue K, Kida H, Yanagita M, Takimoto T, Hirata H, Kijima T, Kumagai T, Osaki T, Tachibana I, Kawase I. Anti-fibrotic effects of theophylline on lung fibroblasts.Biochem Biophys Res Commun. 2006 Mar 17;341(3):684-90. Epub 2006
  2. Nagatomo I, Kumagai T, Yamadori T, Furukawa M, Takahashi R, Yoneda T, Ogata Y, Saito Y, Inoue K, Yano Y, Kijima T, Yoshida M, Osaki T, Tachibana I, Greene MI, Kawase I. The gefitinib-sensitizing mutant epidermal growth factor receptor enables transformation of a mouse fibroblast cell line.DNA Cell Biol. 2006 ;25(4):246-51.
  3. Overexpression of PIAS3 suppresses cell growth and restores drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation.Ogata Y,Osaki T,Naka T,Iwahhori K,Furukawa M,Nagatomo I,Kijima T,Kumagai T,Yoshida M,Tachibana I,Kawase I. Neoplasia vol.8(10) 2006
    ↑■cover pageに掲載されています。■
  4. Yoneda T, Kumagai T, Nagatomo I, Furukawa M, Yamane H, Hoshino S, Mori M, Takeda Y, Horai T, Nishida S, Watanabe D, Kijima T, Yoshida M, Osaki T, Tachibana I, Greene MI, Kawase I. The Extracellular Domain of p185(c-neu) Induces Density-Dependent Inhibition of Cell Growth in Malignant Mesothelioma Cells and Reduces Growth of Mesothelioma In Vivo.DNA Cell Biol. 2006 Sep;25(9):530-40.
  5. Saito Y, Tachibana I, Takeda Y, Yamane H, He P, Suzuki M, Minami S, Kijima T, Yoshida M, Kumagai T, Osaki T, Kawase I. Absence of CD9 Enhances Adhesion-Dependent Morphologic Differentiation, Survival, and Matrix Metalloproteinase-2 Production in Small Cell Lung Cancer Cells. Cancer Res. 2006 Oct 1;66(19):9557-65
2005年
  1. Hoshino, S. Yoshida, M. Inoue, K. Yano, Y. Yanagita, M. Mawatari, H. Yamane, H. Kijima, T. Kumagai, T. Osaki, T. Tachiba, I. Kawase, I. Cigarette smoke extract induces endothelial cell injury via JNK pathway Biochem Biophys Res Commun329(1)58-63,2005
  2. Inoue K, Yoshida M, Arai T, Hoshino S, Yano Y, Yanagita M, Kida H, Takimoto T, Hirata H, Kumagai T, Osaki T, Kijima T, Tachibana I, Kawase I. IL-10 Inhibits Transforming Growth Factor-b-Induction of Type I Collagen mRNA Expression via Both JNK and p38 Pathways in Human Lung Fibroblasts. EXCLI J ;4:49-60 2005
2004年
  1. Kida, H. Yoshida, M. Hoshino, S. Inoue, K. Yano, Y. Yanagita, M. Kumagai, T. Osaki, T. Tachibana, I. Saeki, Y. Kawase, I. Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide Am J Physiol Lung Cell Mol Physiol 288(2)L342-9,2004
  2. Tsuboi, A., Oka, Y., Osaki, T., Kumagai, T., Tachibana, I., Hayashi, S., Murakami,M., Nakajima, H., Elisseeva, O. A., Fei, W., Masuda, T., Yasukawa, M., Oji, Y., Kawakami,M., Hosen, N., Ikegame, K., Yoshihara, S., Udaka, K., Nakatsuka, S., Aozasa,K., Kawase, I., Sugiyama, H. WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer: Report of Two Cases Microbiol Immunol48(3)175-84 2004
  3. Mori, M., Morishita, H., Nakamura, H., Matsuoka, H., Yoshida, K., Kishima,Y., Zhou, Z., Kida, H., Funakoshi, T., Goya, S., Yoshida, M., Kumagai, T., Tachibana,I., Yamamoto, Y., Kawase, I., Hayashi,S. Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth Am J Respir Cell Mol Biol30(4)459-69 2004
  4. Hayashi, S., Abe, K., Matsuoka, H., Goya, S., Morishita, H., Mori, M., Arai,T., Kida, H., Nishino, K., Takeda, Y., Osaki, T., Tachibana, I., Kimura, K., Yokota, S., Inoue, Y., Sakatani, M. Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis. Inflammation 28(1)1-5 2004
2003年
  1. Takeda, Y. Tachibana, I. Miyado, K. Kobayashi, M. Miyazaki, T. Funakoshi,T. Kimura, H. Yamane, H. Saito, Y. Goto, H. Yoneda, T. Yoshida, M. Kumagai, T. Osaki,T. Hayashi, S. Kawase, I. Mekada, E. Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.J Cell Biol 161(5)945-56 2003.
  2. Goya, S. Matsuoka, H. Mori, M. Morishita, H. Kida, H. Kobashi, Y. Kato, T. Taguchi, Y. Osaki,T. Tachibana, I. Nishimoto, N. Yoshizaki, K. Kawase, I. Hayashi, S. Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung . J Pathol 200(1)82-7 2003.
  3. Kumagai, T. Katsumata, M. Hasegawa, A. Furuuchi, K. Funakoshi, T. Kawase,I. Greene, M. I. Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation Proc Natl Acad Sci U S A 100(16)9220-5 2003.
  4. Funakoshi T, Tachibana I, Takeda Y, Kijima T, Nishino K, Goto H, Yoneda T, Kumagai T, Osaki T, Hayashi S, Aozasa K, Kawase I. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer. Oncogene. 2003 Feb 6;22(5):674-87.
2002年
  1. Goto, H., Osaki, T., Nishino, K., Tachibana, I., Takeda, Y., Yoneda,T., Funakoshi, T., Kimura, H., Hayashi, S., and Tahara, H. Constructionand analysis of new vector systems with improved interleukin-18 secretionin a xenogeneic human tumor model, J Immunother. 25 Suppl 1: S35-41., 2002
  2. Matsuoka, H., Arai, T., Mori, M., Goya, S., Kida, H., Morishita, H., Fujiwara, H., Tachibana, I., Osaki, T., and Hayashi, S. A p38 MAPK inhibitor,FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis, Am J Physiol Lung Cell Mol Physiol. 283: L103-12., 2002.
2001年
  1. Suzuki, M.,Kimura, H.Tachibana, I.Fujimura, H.Nakatsuji, Y.Sugai, F.Naba, I.Nakamori, M.Morishita, H.Arai, T.Osaki, T.Hayashi, S. Improvement of anti-Hu-associated paraneoplastic sensory neuropathy after chemoradiotherapy in a small cell lung cancer patient. Intern Med.40(11):1140-3 2001
  2. Goto, H., Osaki, T., Kijima, T., Nishino, K., Kumagai, T., Funakoshi,T., Kimura, H., Takeda, Y., Yoneda, T., Tachibana, I., and Hayashi, S. Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells, Int J Cancer. 94: 414-9., 2001
  3. Nishino, K., Osaki T., Kumagai T., Kijima T., Tachibana, I., Goto H., Arai, T., Kimura, H., Funakoshi, T., Takeda, Y., Tanio, Y., and Hayashi,S. Adenovirus-mediated gene therapy specific for small cell lung cancer cells using a Myc-Max binding motif, Int J Cancer. 91: 851-6., 2001.
  4. Mori, M., Kida, H., Morishita, H., Goya, S., Matsuoka, H., Arai, T., Osaki, T., Tachibana, I., Yamamoto, S., Sakatani, M., Ito, M., Ogura, T., and Hayashi, S. Microsatellite instability in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of idiopathic pulmonary fibrosis, Am J Respir Cell Mol Biol. 24: 398-404., 2001
TOPICS
研究内容
研究業績
スタッフ紹介
診療体制
臨床研修内容・診療実績
研修医募集
大学院生募集
関連施設
フォトコーナー
大阪大学大学院医学系研究科
呼吸器・免疫アレルギー内科学
大阪大学大学院医学系研究科
大阪大学大学医学部附属病院
大阪大学
前期・後期研修医募集
大学院生募集
このページの先頭へ
大阪大学大学院医学系研究科　呼吸器・免疫アレルギー内科学　呼吸器内科（８研） / 大阪大学医学部附属病院　呼吸器内科
Copyright (c) Respiratory Medicine, Allergy and Rheumatic Disease, Graduate School of Medicine, Osaka University. All Rights Reserved.